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Purpose: Epidemic keratoconjunctivitis (EKC) is a contagious acute conjunctivitis associated with community-acquired
infection. Human adenovirus type 8 (HAdV-8) is one of the major serotypes isolated from patients with EKC. DNA
restriction enzyme analyses were performed to investigate the genetic characteristics of the isolates and their chronological
pattern.
Methods: Viral samples were taken from 11 strains isolated from sporadic cases of EKC and identified as HAdV-8 by
the neutralization method with type-specific antiserum against HAdV-8 between 1986 and 2003 in Japan. DNA restriction
enzyme analysis included six restriction enzymes: BamHI, HindIII, PstI, SacI, SalI, and SmaI.
Results: The restriction patterns revealed that the genome types were HAdV-8A and HAdV-8B in 1986, HAdV-8K in
1991, and HAdV-8E in 1996. HAdV-8K was a new genome type revealed with the enzyme SacI. Two strains isolated in
2003 exhibited identical restriction patterns as HAdV-54, which was described in 2008 and collected from Japanese
patients in 2000.
Conclusions: Genetic changes might occur chronologically in HAdV-8. HAdV-8 displays considerable variability. The
investigations of these variants might be helpful for defining the evolutionary tendency and to predict future outbreaks of
HAdV infection.
Human adenoviruses (HAdVs) cause ocular infections.
The most severe disease among ocular infections is epidemic
keratoconjunctivitis  (EKC),  which  is  characterized  by
bilateral, acute, severe keratoconjunctivitis and known for
frequent intrafamilial infection [1]. EKC is commonly caused
by HAdV-8, followed by HAdV-19 and HAdV-37, members
of species D of human adenovirus [2,3]. HAdV-8 was first
described in the United States in 1955, and the virus was
isolated from a sailor (Trim) who had EKC and had arrived
from the Orient [4]. Since that time, HAdV-8 has been isolated
all over the world from typical cases of EKC. Using restriction
enzyme analysis, the serotypes are subclassified into genome
types, nominated according to the chronology reported in the
literature. HAdV-8A and HAdV-8B were shown to have been
circulating in the population of Sapporo, Japan, between 1975
and 1981 [5]. HAdV-8C, D, E, F, G, and H were detected in
Kaohsiung, Taiwan from 1980 to 1994 [2,6,7]. The genome
type  HAdV-8E  was  also  found  in  South  Korea  [8].  In
Australia and the Philippines, only the prototype strain of
HAdV-8  was  found  [9].  HAdV-8I  was  isolated  from  an
outbreak of EKC in 1995 and from sporadic cases until 1997
in Hiroshima, Japan [10]. In Europe, HAdV-8 strains isolated
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in Germany were classified HAdV-8/D1 to HAdV-8/D6, and
substitution of the fastidious Trim strain by the well growing
strain D1 as a prototype was suggested [11]. Later, additional
genome types HAdV-8/D7 to HAdV-8/D10 were reported
[12].  Following  this  nomenclature  system,  genome  types
HAdV-8/D11 and HAdV-8/D12 were isolated in Brazil [13].
To date, HAdV-8A, B, E, and I have been found in Japan
as variants of HAdV-8. Recently, two novel HAdV types
causing nosocomial EKC were reported from Japan [14-16].
One  of  them  has  sometimes  been  mistyped  as  HAdV-8,
because it is similar to HAdV-8 according to neutralization
test  (NT)  and  phylogenetic  analyses.  However,  the  virus
showed completely different restriction patterns from those of
other published HAdV-8 genome types, revealing it is a novel
serotype. It is named as HAdV-54 today [14].
In  the  present  study,  using  HAdV-8  strains  isolated
between 1986 and 2003 in Japan, we reconfirmed the HAdV
type  by  NT  and  phylogeny-based  classification  of  partial
hexon sequences. Moreover, the genetic differences among
the  isolates  were  analyzed  by  DNA  restriction  enzyme
analysis.
METHODS
Viral strains: Eleven strains of HAdV-8 were isolated from
sporadic cases of EKC in Japan (Table 1). Strains number 1,
2, and 3 were isolated in 1986, number 4, 5, and 6 in 1991,
and number 7, 8, and 9 in 1996 in Sapporo, northern part of
Japan. number 10 was isolated in 2003 in Itoman, the Okinawa
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3121region, and number 11 was isolated in 2003 in Matsuyama,
both  are  southweste  area  of  Japan.  All  isolates  were
propagated in A549 cells and identified as HAdV-8 using NT.
The  HAdV-8  prototype  strain  was  purchased  from  the
American Type Culture Collection (Manassas, VA).
Serological  analysis:  Those  11  samples  of  strains  were
serologically  analyzed  by  a  quantitative  serum  NT  with
HAdV-8 type-specific antisera purchased from Denka Seiken
Co.,  Ltd.  (Tokyo,  Japan)  to  confirm  our  previous
classification. NT was performed in A549 cells on 96-well
microplates. The 50% tissue culture infective dose (TCID50)
of each HAdV that caused a cytopathic effect after 7 days of
incubation at 37 °C was calculated, and 100 TCID50s was
used for the challenge virus. Duplicates of the serially twofold
diluted antisera were used in the NT.
Virus propagation and DNA extraction: All of the strains were
inoculated  into  culture  tubes  containing  a  subconfluent
monolayer  of  A549  cells.  The  inoculated  tubes  were
maintained for 1 h at 35 °C for viral absorption, and then 2 ml
of maintenance medium was added. The inoculated cultures
were incubated at 35 °C with medium changes at intervals of
3  or  4  days  and  examined  daily  until  the  appearance  of
cytopathic effects. The viral DNA was extracted following a
previously described protocol with some modifications [17].
The cells were pelleted and rinsed twice with phosphate-
buffered saline  and  then  suspended  in  1  ml  of  Hirt  lysis
solution (10 mM Tris, 1 mM EDTA, 0.6% SDS, pH 8.0).
Proteinase K was added to a final concentration of 50 μg/ml
and the samples incubated at 37 °C for 1 h. Cellular DNA was
precipitated  with  NaCl  (1  M)  overnight  at  4  °C  and
discharged. The supernatant was cleaned with a mixture of
RNases A and T1, proteinase K (200 μg/ml), and phenol-
chloroform  extraction.  Viral  DNA  was  precipitated  with
ethanol and suspended in 50 μl of TE buffer (1 mM Tris-HCl,
0.1 mM EDTA, pH 8.0).
Phylogeny-based classification for HAdV typing: For HAdV
typing,  nucleotide  sequences  in  the  partial  hexon  were
amplified and subjected to phylogenetic analysis as described
previously  [18].  The  nucleotide  sequences  of  the  PCR
products  were  determined  using  a  CEQ  2000XL  DNA
analysis system with a DyeTerminator cycle sequencing kit
(Beckman Coulter, Fullerton, CA) and compared with those
of all HAdV types using SINCA (Fujitsu Limited, Tokyo,
Japan).  The  evolutionary  distances  were  estimated  using
Kimura’s  two-parameter  method  [19],  and  unrooted
phylogenetic  trees  were  constructed  using  the  neighbor-
joining method [20]. Bootstrap analyses were performed with
1,000 resamplings of the data sets.
DNA  restriction  enzyme  analysis:  Aliquots  of  viral  DNA
(2 μl, approximately 1 μg) were digested with 10 units of
restriction  enzymes  BamHI,  HindIII,  PstI,  SacI,  SalI,  and
SmaI under conditions specified by the manufacturer (Takara
Shuzo Co., Kyoto, Japan). Restriction enzyme digests were
loaded onto 1.5% agarose gels and run for approximately 2 h
at 100 V in Tris-acetate buffer (pH 8.0) with 1 mM EDTA.
After staining with ethidium bromide (1 μg/ml), the fragments
were visualized under UV transilluminator and photographed
with  a  PolaroidTM  camera.  Subgenus  and  genome  type
identification  was  performed  by  comparing  the  resulting
patterns  with  the  published  restriction  patterns  of  the
prototypes and genome types.
RESULTS
Serological  analysis:  Eleven  strains  of  samples  were
specifically neutralized with the antiserum against HAdV-8.
However, strains of number 10 and 11 isolated in 2003 reacted
to HAdV-8 antiserum only at 1:32 and 1:16 of homologous
titer  respectively,  a  weak  reaction  for  the  immunological
distinctiveness of serotype (Table 1). No other prototype-
specific antiserums reacted with these 2 strains. These strains
of number 10 and 11 collected in Itoman and Matsuyama were
considered as one of the HAdV-8s at that time.
HAdV  typing  of  phylogeny-based  classification:  The
nucleotide sequences of the partial hexon gene were compared
with those of all HAdV prototype strains. Strains of number
1 to 9 were clustered in HAdV-8, however number 10 and
TABLE 1. SUMMARY OF GENOME TYPE OF 11 HADV STRAINS ISOLATED IN JAPAN DURING 1986–2003.
      Enzyme code*  
Strains of
samples
Genome types Years
collected
BamHI HindIII PstI SacI SalI SmaI Neutralization
test titer
Samples collected
in
  HAdV-8P 1955 1 1 1 1 1 1 >64 (ATCC)
1 HAdV-8A 1986 2 2 2 2 2 2 >64 Sapporo
2,3 HAdV-8B 1986 2 2 2 2 3 2 >64 Sapporo
4,5,6 HAdV-8K 1991 2 3 2322 >64 Sapporo
7,8,9 HAdV-8E 1996 2 3 2222 >64 Sapporo
10 HAdV-54 2003 3 4 3 4 4 3 32 Itoman
11 HAdV-54 2003 3 4 3 4 4 3 16 Matsuyama
         *Enzyme codes are displayed in alphabetical order: BamHI, HindIII, PstI, SacI, SalI, SmaI. The restriction patterns of HAdV-8P
         for each enzyme are called number 1. The other patterns are consecutively numbered in chronological order of appearance. The
         numbering in this study was performed according to the methods of previous report [25]. HAdV-8P: HAdV-8 prototype.
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312211were in HAdV-54 (data not shown). Strains of number 10
and 11 were reclassified as HAdV-54.
DNA restriction enzyme analysis: After restriction enzyme
digestion, the 11 strains were electrophoresed in two gels.
Strains of number 1 to 9 isolated in 1986, 1991, and 1996 that
reacted strongly to HAdV-8 antiserum were run in one gel
(Figure 1A). The remaining 2 strains of number 10 and 11
isolated in 2003 showing weak reaction to HAdV-8 antiserum
were run in another gel (Figure 2A). To make the restriction
patterns of these strains are easy to read, they were also shown
Figure 1. Restriction patterns of strains number 1–9. A: Restriction patterns of 9 strains isolated in 1986, 1991, and 1996. Lane M: molecular
weight marker (lambda DNA digested with EcoT14I). Lane 1: representative strains number 1–3 isolated in 1986. Lanes 1a and 1b represent
the two kinds of restriction patterns for SalI (HAdV-8A and HAdV-8B). Lane 2: representative strains number 4–6 isolated in 1991
(HAdV-8K). Lane 3: representative strains number 7–9 isolated in 1996 (HAdV-8E). B: Schematic presentation of the restriction patterns of
strains number 1–9 and HAdV-8 prototype.
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3123Figure 2. Restriction patterns of strains number 10 and 11. A: Restriction patterns of 2 strains isolated in 2003. Lane m: molecular weight
marker (lambda DNA digested with EcoT14I plus BglII). Lane P: HAdV-8 prototype. Lane 1: representative strains number 10 isolated in
Itoman in 2003 (HAdV-54). Lane 2: representative strains number 11 isolated in Matsuyama in 2003 (HAdV-54). B: Schematic presentation
of the restriction patterns of strains HAdV-8 prototype and samples number 10 and 11.
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3124as schematic presentations (Figure 1B and Figure 2B). It was
revealed that the 11 strains analyzed in this study were divided
into five genome types according to the profile of restriction
patterns  (Table  1).  All  of  11  strains  showed  different
restriction patterns from those of the HAdV-8 prototype. Of
the 3 strains isolated in 1986, number 1 showed restriction
patterns similar to HAdV-8A and number 2 and 3 were similar
to HAdV-8B. number 4 to 6 isolated in 1991, and number 7
to 9 isolated in 1996 showed identical restriction patterns with
restriction  endonucleases  BamHI,  HindIII,  PstI,  SalI,  and
SmaI. With SacI, the strains number 4 to 6 isolated in 1991
exhibited different patterns from those of the strains isolated
in 1996 and any other previously known HAdV-8 genome
types.  This  new  pattern  revealed  a  new  genome  type  of
HAdV-8 that we designated as HAdV-8K in accordance with
the serial studies in the Asia Pacific area. The restriction
patterns of strains number 7 to 9 isolated in 1996 corresponded
to HAdV-8E. The restriction patterns of strains number 10 and
11 isolated in 2003 were similar to those of HAdV-54. The
results of DNA restriction enzyme analysis are summarized
in Table 1.
DISCUSSION
To investigate the genetic characteristics of HAdV-8 isolates
and  their  chronological  pattern,  we  demonstrated  the
molecular biologic characteristics of 11 HAdV strains isolated
from sporadic cases of EKC in Japan over an 18-year period
in the present study. All of the strains were identified as
HAdV-8 by the neutralization method. In the present study, a
new variant strain, HAdV-8K, was identified by the DNA
restriction method. The DNA restriction method for genome
typing identified two strains isolated in 2003 as HAdV-54, not
HAdV-8.  These  were  also  confirmed  as  HAdV-54  by
phylogenetic analysis of partial hexon gene. HAdV-54 was
not detected before the early 1990s, but replaced HAdV-8 in
Japan in the 2000s [21]. HAdV-54 in samples collected in
2003 is consistent with that study. However, major causes of
EKC vary in different countries, and HAdV-8 is still the most
common pathogenic virus in the Middle East [22].
As HAdV-8 has a much higher tropism for conjunctival
cells and produces more severe clinical manifestations and
pathological alterations in EKC than HAdV-19 or HAdV-37,
HAdV-8 has been the target of extensive study [10]. After
HAdV-8  was  first  isolated  as  an  etiology  of  EKC,  many
HAdV-8  genome  types  have  been  identified  by  applying
restriction endonucleases and cleavage pattern analysis [7].
Distinct  nomenclature  systems  have  been  used  for  these
genome types. A nomenclature system using a numerical code
to denote adenovirus genome types has been proposed, and
HAdV-8/D1 to HAdV-8/D12 have been described depending
on the chronological order of the respective isolates [11-13].
Another nomenclature system was also proposed in which
HAdV-8 genome types are denoted by alphabetical order [5].
According  to  the  nomenclature  system,  HAdV-8  genome
types are classified as HAdV-8A to HAdV-8K [5-7,10,23].
Although both systems are commonly used, we adopted the
latter nomenclature system here in accordance with a series
of  collaborative  studies  of  HAdV-8.  We  compared  the
restriction patterns of the strains in this study with those of all
previously  known  genome  types  of  HAdV-8.  One  new
genome type was discovered and designated as HAdV-8K.
The cleavage patterns of 2 strains isolated in 2003 with
any of the 6 restriction endonucleases were different from
those of any other previously known genome type of HAdV-8.
The unique restriction patterns indicated that an uncommon
mutation or recombination event might have occurred. The
restriction patterns of these 2 strains were consistent with
those of HAdV-54, which was first reported in 2008 [14].
Furthermore, these strains were neutralized weakly by the
antiserum against HAdV-8. Similarly, HAdV-54 responds
weakly to the antiserum for HAdV-8. Because of the absence
of serotype specific antiserum, the weak reaction with the
antiserum  against  HAdV-8  might  be  a  clue  for  detecting
HAdV-54 at the current time. The strains of number 10 and
11 were also confirmed as HAdV-54 by phylogeny-based
classification,  which  is  an  effective  tool  for  the  rapid
identification of HAdVs.
Although  HAdV-8  seems  to  display  considerable
variability and adenoviral ocular infection is common in East
Asian countries, few studies on the circulation of HAdV-8
genome types have been reported in Japan. Thus, this is a
report even more focused on the genetic characteristics of
HAdV-8 isolates and their chronological patterns than the
analysis of a new genome type. Two studies reported the
isolation of HAdV-8A and HAdV-8B in Sapporo [5], and the
circulation of HAdV-8 genome types in Hiroshima over a 15-
year  period  [10].  In  this  study,  restriction  endonuclease
analyses revealed a new genome type, HAdV-8K, in Sapporo,
where HAdV-8A and HAdV-8B are endemic. The strains
isolated  in  1986  were  HAdV-8A  and  HAdV-8B,  and
HAdV-8K strains were isolated from samples collected in
1991.  The  strains  isolated  in  1996  exhibited  a  similar
restriction  pattern  as  that  of  HAdV-8E,  which  was  first
isolated in Kaohsiung, Taiwan [6]. HAdV-8 was reported as
being prevalent in 1986, 1991, and 1996 in Sapporo [2,24].
Our  present  results  show  that  different  genome  types  of
HAdV-8 appeared in the three prevalence periods, which may
indicate that a change in genome type resulted in the next
prevalence  period  of  HAdV-8.  On  the  other  hand,  high
frequency  of  infection  in  the  population  is  regarded  as  a
probable reason for the diverse evolution of HAdV-8 [7]. As
HAdV-8 has become less common in Japan since 1997, a
follow-up study of HAdV-8 should be completed in Japan and
why we conducted this study.
HAdV-54 has recently been the major cause of EKC in
Japan. The strain has occasionally been identified as HAdV-8
due to its weak reaction to HAdV-8 antiserum. On the basis
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3125of  the  nucleotide  sequence  identities  and  phylogenetic
analysis, HAdV-54 was much closer to the HAdV-8 strains
over the entire genome than other HAdVs [15].
Our results show that genetic changes in HAdV-8 occur
chronologically. HAdV-8 displays considerable variability.
Because continued investigations of these variants might be
helpful for defining the evolutionary tendency and to predict
future  outbreaks  of  HAdV  infection,  further  genetic,
epidemiological, and clinical surveillance of HAdVs should
be performed.
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